Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

NCT02267512 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

De Novo Kidney Transplant Patients

Interventions

DRUG: ATG-F

Sponsor

Astellas Pharma Inc